Treatment of Chronic Lymphocytic Leukemia With the Use of an Antiviral Compound - a Proof of Principle Study.
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Valganciclovir (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Acronyms VGCV-CLL
- 20 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 29 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Dec 2010 New trial record